Statistical Assessment of National Significant Industrial User Noncompliance for Pre-Treatment of Wastewater DischargesDIANE Publishing, 1993 - 110 pages |
Contents
| 27 | |
| 28 | |
| 31 | |
| 32 | |
| 35 | |
| 36 | |
| 38 | |
| 39 | |
| 40 | |
| 41 | |
| 42 | |
| 43 | |
| 44 | |
| 55 | |
| 61 | |
| 64 | |
| 68 | |
| 69 | |
| 70 | |
| 71 | |
| 72 | |
| 74 | |
| 75 | |
| 78 | |
| 79 | |
| 93 | |
| 95 | |
| 97 | |
| 99 | |
| 102 | |
| 104 | |
| 105 | |
| 109 | |
| 110 | |
| 112 | |
| 113 | |
| 116 | |
| 117 | |
| 118 | |
| 119 | |
| 120 | |
| 121 | |
| 122 | |
| 123 | |
| 124 | |
| 127 | |
| 147 | |
| 149 | |
| 153 | |
| 167 | |
Other editions - View all
Common terms and phrases
acute phase treatment acute treatment adherence alprazolam amitriptyline amoxapine antidepressant medications Arch Gen Psychiatry associated behavioral therapy blood levels brief dynamic psychotherapy bupropion Clin Psychiatry clinical management cognitive therapy combined treatment continuation treatment Department of Psychiatry depressed patients Depression Guideline Panel depressive symptoms desipramine diagnosis DiMascio discontinuation double-blind drug Electroconvulsive therapy episodes of major evaluation fluoxetine followup formal psychotherapy geriatric imipramine intent-to-treat interpersonal psychotherapy Klerman light therapy maintenance medication maintenance treatment major depressive disorder MAOIS maprotiline marital therapy Medical Center medical conditions medical disorders medication trials Medicine Mental Health meta-analysis N/A N/A N/A NIMH nortriptyline optimal outcome paroxetine partial response patients with major percent pharmacotherapy phase psychotherapy placebo practitioner primary care settings Prusoff Quitkin randomized controlled trials recommended relapse relapse/recurrence remission Research response rate selected side effects Strength of Evidence studies suicide TCAs trazodone treatment of depression treatment of major tricyclic tricyclic antidepressants wait-list Weissman
Popular passages
Page 128 - Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
Page 84 - ... of major depressive disorder is sparse (Table 12). Few studies have directly compared one psychotherapy to another. Furthermore, studies to date have been conducted largely at sites closely associated with the development or administration of one of these methods. Whether the comparison therapy(ies) was (were) administered with equal skill and enthusiasm (which could potentially bias findings) is unclear. When formal psychotherapy is selected as the sole treatment for less severe episodes of...
Page 136 - ... drugs. References: 1. Mendels J, Amin MM, Chouinard G, et al. A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry. 1983;44(5. sec 2):1 18-120.
Page 164 - Community Mental Health Centers Rockville, Maryland Frederick K. Goodwin, MD Director, National Institute of Mental Health Bethesda, Maryland Edgar Heim, MD Professor and Co-chair Psychiatrische Univ. Poliklinik Bern, Switzerland Shirley Hibbeln Education Consultant National Depressive and Manic-Depressive Association Chicago, Illinois Robert MA Hirschfeld, MD Professor and Chairman, Department of Psychiatry University of Texas Medical Branch Galveston, Texas IMCARE Practice Guidelines Network IMCARE...
Page 12 - Peer review requested from 73 organizations and 14 new scientific reviewers, pilot review of A Patient's Guide, Quick Reference Guide for Clinicians, and Clinical Practice Guideline in nine sites I Critiques from peer/pilot review considered by panel 4...
Page 155 - ... axis dysfunction in patients with primary affective disorder. Dr. Kathol has lectured widely, is on the editorial board of several journals, holds membership on the boards of national organizations, and is published widely in the area of psychiatric pathology as seen in medically ill patients. He is board-certified in both internal medicine and psychiatry, and is a Fellow of the American College of Physicians, the American Psychiatrie Association, and the American Academy of Psychosomatic Medicine.
Page v - Depression may co-occur with nonpsychiatric medical disorders or with other psychiatric disorders; it may also be brought on by the use of certain medications. Major risk factors for depression include a personal or family history of depressive disorder, prior suicide attempts, female gender, lack of social supports, stressful life events, and current substance abuse. The social stigma surrounding depression is substantial and often prevents the optimal use of current knowledge and treatments. The...
Page 7 - Executive Summary Up to one in eight individuals may require treatment for depression during their lifetimes. The direct costs of treatment for major depressive disorder combined with the indirect costs from lost productivity are significant, accounting for approximately $16 billion per year in 1980 dollars.
Page 127 - Anderson CM, Griffin S, Rossi A, Pagonis I, Holder DP, Treiber R. A comparative study of the impact of education vs. process groups for families of patients with affective disorders. Fam Process 1986;25(2): 185-205. . Anton RF, Burch EA. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry 1990; 147(9): 1203-8.
Page 133 - Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.